May 14, 2015
Healthcare Provider Reps Make Many Comments at Chuikyo on May 13 Gilead Sciences K.K.’s hepatitis C drug Sovaldi (sofosbuvir) stirred up various discussions on May 13 among members of the Central Social Insurance Medical Council, better known as Chuikyo, with...read more